Was has previously been shown to underlie Wiskott-Aldrich syndrome which is characterized by defective clotting and immune function and although Was has not been previously identified as a candidate gene for atherosclerosis, altered clotting function and immune function are thought to contribute to atherosclerotic lesion development. Here, WAS is linked to Wiskott-Aldrich syndrome.